It is challenging for a surgeon to determine the appropriate vascular access for hemodialysis patients whose cephalic vein is usually inaccessible. The purpose of the study is to compare the complications and patency rates between transposed arteriovenous fistulas (tAVF) and arteriovenous graft (AVG) for the hemodialysis patients. Studies were recruited from PubMed, Cochrane library, EMBASE, the web of science databases, and reviewing reference lists of related studies from the inception dates to September 2, 2021. Statistical analyses were conducted using the statistical tool Review Manager version5.3 (Cochrane Collaboration, London, UK). I2 > 50% was defined as a high degree of heterogeneity, and then a random-effects model was used. Otherwise, the fixed-effects model was used. Odds ratio with its 95% confidence interval (95% CI) was used. Thirty-three trials (26 retrospective studies, four randomized controlled trials, two prospective trials, and one controlled-comparative study) with 6430 enrolled participants were identified in our analysis. The results showed that tAVF was accompanied with lower thrombosis rate (103/1184 (8.69%) vs 257/1367 (18.80%); I2 = 45%; 95% CI, 0.34 (0.26, 0.45)) and infection rate (43/2031 (2.12%) vs 180/2147 (8.38%); I2 = 0%; 95% CI, 0.20 (0.14, 0.30)) than arteriovenous graft. The significantly better primary patency rates, secondary patency rates, and primary assisted patency rates during follow-up were found in tAVF. However, the failure rate and the prevalence of hematoma were significantly lower in AVG group. No evidence showed the rate of overall mortality, steal syndrome, and aneurysm reduced in tAVF. Our results showed that tAVF is a promising vascular access technique for hemodialysis patients whose cephalic vein is inaccessible. Our data showed that tAVF has less thrombosis, infection risk, and better patency rates when compared with AVG. However, more attentions need to be paid to transposed arteriovenous fistulas maturation and hematoma.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl2013; 3: 1–150.
2.
ShlipakMGTummalapalliSLBoulwareLE, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving Global Outcomes (KDIGO) controversies conference. Kidney Int2021; 99(1): 34–47.
3.
Palmer AlvesTLewisJ. Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma. Clin Nephrol2010; 74Suppl 1: S72–S77.
4.
YangCWHarrisDCLuyckxVA, et al. Global case studies for chronic kidney disease/end-stage kidney disease care. Kidney Int Suppl2020; 10(1): e24–e48.
5.
ChanCTBlankestijnPJDemberLM, et al. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int2019; 96(1): 37–47.
6.
LvJCZhangLX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol2019; 1165: 3–15.
7.
KaplanAA. Peritoneal dialysis or hemodialysis: present and future trends in the United States. Contrib Nephrol2017; 189: 61–64.
8.
LokCEHuberTSLeeT, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis2020; 75(4 Suppl 2): S1–S164.
9.
ViecelliAKLokCE. Hemodialysis vascular access in the elderly-getting it right. Kidney Int2019; 95(1): 38–49.
10.
PisoniRLZepelLFluckR, et al. International differences in the location and use of arteriovenous accesses created for hemodialysis: results from the dialysis outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis2018; 71(4): 469–478.
11.
LokCESontropJMTomlinsonG, et al. Cumulative patency of contemporary fistulas versus grafts (2000-2010). Clin J Am Soc Nephrol2013; 8(5): 810–818.
12.
HaddadDJJastyVSMohanB, et al. Comparing outcomes of upper extremity brachiobasilic arteriovenous fistulas and arteriovenous grafts: a systematic review and meta-analysis. J Vasc Access2022; 23: 32–41.
13.
SidawyANGrayRBesarabA, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg2002; 35(3): 603–610.
14.
WealeARBevisPNearyWD, et al. A comparison between transposed brachiobasilic arteriovenous fistulas and prosthetic brachioaxillary access grafts for vascular access for hemodialysis. J Vasc Surg2007; 46(5): 997–1004.
15.
AkohJA. Adoption of transposed basilic vein as access for hemodialysis. Saudi J Kidney Dis Transpl2018; 29(2): 381–385.
16.
BaselHEkimHOdabasiD, et al. Basilic vein transposition fistulas versus prosthetic bridge grafts in patients with end-stage renal failure. Ann Vasc Surg2011; 25(5): 634–639.
17.
MorosettiMCiprianiSDominijanniS, et al. Basilic vein transposition versus biosynthetic prosthesis as vascular access for hemodialysis. J Vasc Surg2011; 54(6): 1713–1719.
18.
GonzaloBHuiciMEsturricaM, et al. Brachiobasilic arteriovenous fistulas do better than brachioaxillary access grafts in terms of patency and complications: a single centre study. Eur J Vasc Endovasc Surg2019; 58(6): e329–e330.
19.
LeeCHKoPJLiuYH, et al. Brachiobasilic fistula as a secondary access procedure: an alternative to a dialysis prosthetic graft. Chang Gung Med J2004; 27(11): 816–823.
20.
LioupisCMistryHRixT, et al. Comparison among transposed brachiobasilic, brachiobrachial arteriovenous fistulas and flixene™ vascular graft. J Vasc Access2011; 12(1): 36–44.
21.
ChengCTChangYCTamKW, et al. Comparison between transposed brachiobasilic fistula and arteriovenous graft for upper limb arteriovenous access in patients on hemodialysis. Vasc Endovascular Surg2021; 55(2): 164–170.
22.
CoburnMCCarneyWIJr. Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg1994; 20(6): 896–902; discussion 903.
23.
WooKDorosGNgT, et al. Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts. J Vasc Surg2009; 50(6): 1405–1411.
24.
OliverMJMcCannRLIndridasonOS, et al. Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. Kidney Int2001; 60(4): 1532–1539.
25.
ChueKMThantKZLuoHD, et al. Comprehensive comparison of the performance of autogenous brachial-basilic transposition arteriovenous fistula and prosthetic forearm loop arteriovenous graft in a multiethnic Asian hemodialysis population. Biomed Res Int2016; 2016: 8693278.
26.
SonHJMinSKMinSI, et al. Evaluation of the efficacy of the forearm basilic vein transposition arteriovenous fistula. J Vasc Surg2010; 51(3): 667–672.
27.
ItogaNKVirgin-DownyWMellMW. Forearm loop arteriovenous grafts preserve and may create new upper arm access sites. J Vasc Access2019; 20(6): 691–696.
28.
MarquesGSadaghianlooNFouilhéL, et al. Higher patency of transposed brachio-basilic arteriovenous fistulas compared to brachio-axillary grafts for hemodialysis patients. J Vasc Access2015; 16(6): 486–492.
29.
ChemlaESMorsyMA. Is basilic vein transposition a real alternative to an arteriovenous bypass graft? A prospective study. Semin Dial2008; 21(4): 352–356.
30.
HammadAAbdel ModaberAMAliyevV. Native versus synthetic AV fistula for hemodialysis access in obese patients. J Surg2018; 8: 1138.
31.
DrouvenJWde BruinCvan RoonAM, et al. Outcomes of basilic vein transposition versus polytetrafluoroethylene forearm loop graft as tertiary vascular access. J Vasc Surg2019; 69(4): 1180–1186.
32.
MayaIDO’NealJCYoungCJ, et al. Outcomes of brachiocephalic fistulas, transposed brachiobasilic fistulas, and upper arm grafts. Clin J Am Soc Nephrol2009; 4(1): 86–92.
33.
KaweckaADębska-ślizieńAPrajsJ, et al. Remarks on surgical strategy in creating vascular access for hemodialysis: 18 years of one center’s experience. Ann Vasc Surg2005; 19(4): 590–598.
34.
BenedettoBJMaddenRLKurbanovA, et al. Transposed basilic vein fistula: a superior alternative to prosthetic grafts?Curr Surg2000; 57(5): 503–504.
35.
MatsuuraJHRosenthalDClarkM, et al. Transposed basilic vein versus polytetrafluorethylene for brachial-axillary arteriovenous fistulas. Am J Surg1998; 176(2): 219–221.
36.
PfledererTAKwokSKetelBL, et al. A comparison of transposed brachiobasilic fistulae with nontransposed fistulae and grafts in the Fistula First era. Semin Dial2008; 21(4): 357–363.
37.
TorinaPJWestheimerEFSchanzerHR. Brachial vein transposition arteriovenous fistula: is it an acceptable option for chronic dialysis vascular access?J Vasc Access2008; 9(1): 39–44.
38.
KimHAhnSKimM, et al. Comparison between autogenous brachial-brachial upper-arm elevated direct arteriovenous fistulas and prosthetic brachial-antecubital indirect forearm arteriovenous grafts. J Vasc Access2021; 31: 11297298211018020.
39.
Sala AlmonacilVPlaza MartínezAZaragozá GarcíaJ, et al. Comparison between autogenous brachial-basilic upper arm transposition fistulas and prosthetic brachial-axillary vascular accesses for hemodialysis. J Cardiovasc Surg2011; 52(5): 725–730.
40.
KeuterXHDe SmetAAKesselsAG, et al. A randomized multicenter study of the outcome of brachial-basilic arteriovenous fistula and prosthetic brachial-antecubital forearm loop as vascular access for hemodialysis. J Vasc Surg2008; 47(2): 395–401.
41.
TayebiPKazemzadehGModagheghMHS, et al. Brachio-basilic upper arm transposition fistulas vs. prosthetic brachio-axillary vascular access grafts-which one is preferred for hemodialysis?Hemodial Int2020; 24(2): 182–187.
42.
DavoudiMTayebiPBeheshtianA. Primary patency time of basilic vein transposition versus prosthetic brachioaxillary access grafts in hemodialysis patients. J Vasc Access2013; 14(2): 111–115.
43.
GibsonKDGillenDLCapsMT, et al. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis morbidity and mortality study. J Vasc Surg2001; 34(4): 694–700.
44.
GunawansaNWolfB. Transposed brachio-basilic arterio-venous fistulae versus prosthetic arteriovenous grafts; mid-term results and a review of literature. Sri Lanka J Surg2017; 35(2): 7–15.
45.
MilburnJALoSTSzucsZJ, et al. Transposed brachiobasilic fistula or PTFE arm graft - alternative or complementary?J Vasc Access2008; 9(2): 117–121.
46.
KakkosSKAndrzejewskiTHaddadJA, et al. Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment. J Vasc Surg2008; 47(2): 407–414.
47.
ShetaMHakmeiJLondonM, et al. One- versus two-stage transposed brachiobasilic arteriovenous fistulae: a review of the current state of the art. J Vasc Access2020; 21(3): 281–286.
48.
SmithGESouroullosPCaytonT, et al. A systematic review and meta-analysis of systemic intraoperative anticoagulation during arteriovenous access formation for dialysis. J Vasc Access2016; 17(1): 1–5.
49.
CozzolinoMManganoMStucchiA, et al. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant2018; 33(suppl_3): iii28–iii34.
50.
RavaniPPalmerSCOliverMJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol2013; 24(3): 465–473.
ChenCFLinCC. The association of genotype polymorphisms with vascular access patency in hemodialysis patients. J Vasc Access2019; 20(1_suppl): 24–30.
56.
AllonM. Vascular access for hemodialysis patients: new data should guide decision making. Clin J Am Soc Nephrol2019; 14(6): 954–961.
57.
RemuzziABozzettoM. Biological and physical factors involved in the maturation of arteriovenous fistula for hemodialysis. Cardiovasc Eng Technol2017; 8(3): 273–279.
58.
BeathardGAArnoldPJacksonJ, et al. Aggressive treatment of early fistula failure. Kidney Int2003; 64(4): 1487–1494.
59.
QuencerKBAriciM. Arteriovenous fistulas and their characteristic sites of stenosis. AJR Am J Roentgenol2015; 205(4): 726–734.
60.
ViecelliAKMoriTARoy-ChaudhuryP, et al. The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: optimism unfulfilled. Semin Dial2018; 31(3): 244–257.
61.
KumbarLYeeJ. Current concepts in hemodialysis vascular access infections. Adv Chronic Kidney Dis2019; 26(1): 16–22.
62.
RobinsonTGearyRLDavisRP, et al. Arteriovenous fistula versus graft access strategy in older adults receiving hemodialysis: a pilot randomized trial. Kidney Med2021; 3(2): 248–256.e1.
